Tokyo Tape
Sign in
← MedPeer

Quarterly report · Q3

6095.TEDINET S100RKWX
Period2022-10-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥10.7bn2022-10-01 → 2023-06-30Cons.Net sales
Revenue¥8.5bn2021-10-01 → 2022-09-30Cons.Net sales (5-year summary)
Revenue¥6.4bn2021-10-01 → 2022-06-30Cons.Net sales
Operating income¥825m2022-10-01 → 2023-06-30Cons.Operating income
Operating income¥907m2021-10-01 → 2022-06-30Cons.Operating income
Ordinary income¥854m2022-10-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥1.1bn2021-10-01 → 2022-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥943m2021-10-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥854m2022-10-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥943m2021-10-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥409m2022-10-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥812m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥655m2021-10-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥414m2022-10-01 → 2023-06-30Cons.Profit loss
Net income¥651m2021-10-01 → 2022-06-30Cons.Profit loss
Total assets¥14.1bnat 2023-06-30Cons.Assets
Total assets¥9.4bnat 2022-09-30Cons.Assets
Total assets¥9.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2023-06-30Cons.Liabilities
Total liabilities¥1.5bnat 2022-09-30Cons.Liabilities
Net assets / equity¥8.4bnat 2023-06-30Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥7.7bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥5.4bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥6.1bnat 2022-09-30Cons.Cash and deposits
EPS (basic)¥18.712022-10-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.292023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥37.622021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.332021-10-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥2.592022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥18.282022-10-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.782021-10-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥28.762021-10-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio57.5%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio80.6%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-06-30−¥6m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-06-30−¥6m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-06-30−¥1.0bn
jpcrp040300-q3r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2023-06-30¥8.6bn
jpcrp040300-q3r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2023-06-30¥8.6bn
jpcrp040300-q3r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2023-06-30¥3m
jpcrp040300-q3r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2023-06-30¥1.8bn
jpcrp040300-q3r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2023-06-30¥371m
jpcrp040300-q3r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2023-06-30¥368m
jpcrp040300-q3r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2023-06-30¥3m
jpcrp040300-q3r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2023-06-30−¥65m
jpcrp040300-q3r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2023-06-30¥1.7bn
jpcrp040300-q3r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2023-06-30¥1.7bn
jpcrp040300-q3r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2023-06-30¥463,000
jpcrp040300-q3r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2023-06-30¥103m
—segment totalrevenue2022-10-01 → 2023-06-30¥10.7bn
—segment totalrevenue external2022-10-01 → 2023-06-30¥10.7bn
—segment totalrevenue intersegment2022-10-01 → 2023-06-30¥6m
—segment totalsegment profit2022-10-01 → 2023-06-30¥1.8bn
Reconciling Itemsreconcilingrevenue2021-10-01 → 2022-06-30−¥12m
Reconciling Itemsreconcilingrevenue intersegment2021-10-01 → 2022-06-30−¥12m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-06-30−¥1.0bn
jpcrp040300-q3r_E30650-000Collective Intelligence Platformreportable segmentrevenue2021-10-01 → 2022-06-30¥4.6bn
jpcrp040300-q3r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2021-10-01 → 2022-06-30¥4.6bn
jpcrp040300-q3r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2021-10-01 → 2022-06-30¥4m
jpcrp040300-q3r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2021-10-01 → 2022-06-30¥1.8bn
jpcrp040300-q3r_E30650-000Medical Institution Support Platformreportable segmentrevenue2021-10-01 → 2022-06-30¥319m
jpcrp040300-q3r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2021-10-01 → 2022-06-30¥315m
jpcrp040300-q3r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2021-10-01 → 2022-06-30¥4m
jpcrp040300-q3r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2021-10-01 → 2022-06-30¥42m
jpcrp040300-q3r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2021-10-01 → 2022-06-30¥1.5bn
jpcrp040300-q3r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2021-10-01 → 2022-06-30¥1.5bn
jpcrp040300-q3r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2021-10-01 → 2022-06-30¥4m
jpcrp040300-q3r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2021-10-01 → 2022-06-30¥100m
—segment totalrevenue2021-10-01 → 2022-06-30¥6.5bn
—segment totalrevenue external2021-10-01 → 2022-06-30¥6.4bn
—segment totalrevenue intersegment2021-10-01 → 2022-06-30¥12m
—segment totalsegment profit2021-10-01 → 2022-06-30¥1.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 359
ItemContextValueUnit
Valuation and translation adjustmentsPrior1YearInstant-11046000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-12188000JPY
Subscription rights to sharesPrior1YearInstant9578000JPY
Subscription rights to sharesCurrentQuarterInstant8778000JPY
Non controlling interestsPrior1YearInstant270848000JPY
Non controlling interestsCurrentQuarterInstant276442000JPY
Net assetsPrior1YearInstant7863203000JPY
Net assetsCurrentQuarterInstant8362579000JPY
Liabilities and net assetsPrior1YearInstant9351008000JPY
Liabilities and net assetsCurrentQuarterInstant14050109000JPY
Net salesPrior1YTDDuration6443320000JPY
Net salesCurrentYTDDuration10682957000JPY
Cost of salesPrior1YTDDuration2629083000JPY
Cost of salesCurrentYTDDuration5564021000JPY
Gross profitPrior1YTDDuration3814236000JPY
Gross profitCurrentYTDDuration5118936000JPY
Selling general and administrative expensesPrior1YTDDuration2906831000JPY
Selling general and administrative expensesCurrentYTDDuration4294059000JPY
Operating incomePrior1YTDDuration907405000JPY
Operating incomeCurrentYTDDuration824877000JPY
Interest income noiPrior1YTDDuration154000JPY
Interest income noiCurrentYTDDuration131000JPY
Equity in earnings of affiliates noiPrior1YTDDuration36302000JPY
Equity in earnings of affiliates noiCurrentYTDDuration41636000JPY
Subsidy income noiPrior1YTDDuration463000JPY
Subsidy income noiCurrentYTDDuration1815000JPY
Other noiPrior1YTDDuration1616000JPY
Other noiCurrentYTDDuration1593000JPY
Non operating incomePrior1YTDDuration38536000JPY
Non operating incomeCurrentYTDDuration45176000JPY
Interest expenses noePrior1YTDDuration750000JPY
Interest expenses noeCurrentYTDDuration10183000JPY
Foreign exchange losses noePrior1YTDDuration5000JPY
Foreign exchange losses noeCurrentYTDDuration294000JPY
Shouhizeisagaku noePrior1YTDDuration1589000JPY
Shouhizeisagaku noeCurrentYTDDuration－JPY
Commission for purchase of treasury stock noePrior1YTDDuration－JPY
Commission for purchase of treasury stock noeCurrentYTDDuration1020000JPY
Other noePrior1YTDDuration158000JPY
Other noeCurrentYTDDuration4692000JPY
Non operating expensesPrior1YTDDuration2504000JPY
Non operating expensesCurrentYTDDuration16191000JPY
Ordinary incomePrior1YTDDuration943436000JPY
Ordinary incomeCurrentYTDDuration853862000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration47000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration47000JPY
Extraordinary incomeCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration943483000JPY
Income before income taxesCurrentYTDDuration853862000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-09-30pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-06-30pass
statement vs summary · revenueconsolidated 2021-10-01/2022-06-30pass
statement vs summary · revenueconsolidated 2022-10-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2023-06-30pass